tradingkey.logo
tradingkey.logo

Eli Lilly To Sign $2 Bln Deal For AI Drug Development With Hong Kong Biotech Insilico Medicine - FT

ReutersMar 29, 2026 11:06 AM

-

  • ELI LILLY TO SIGN $2BN DEAL FOR AI DRUG DEVELOPMENT WITH HONG KONG BIOTECH INSILICO MEDICINE - FT

  • LILLY WILL ACQUIRE EXCLUSIVE RIGHTS TO SELL A GLP-1 DRUG FOR DIABETES FROM INSILICO MEDICINE - FT

Source text: https://tinyurl.com/yrh4f2hz

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI